The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
NCT ID: NCT01856387
Last Updated: 2014-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2013-05-31
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Neutrophil/Lymphocyte Ratio ,Platelet/Lymphocyte Ratio and CRP as Markers of Severity of Pre-eclampsia
NCT03630276
Inflammation Markers in Hyperemesis Gravidarum
NCT06245811
Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
NCT01388283
Maternal Serum BLyS Levels Throughout Pregnancy
NCT03364712
Are Uterine Natural Killer Cells Involved in the Initiation of Preterm Labor ?
NCT02284867
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
An elevated NLR has been shown to be a prognostic indicator in various malignancies. İn the literatüre have been shown that NLR have predictive value in determining the prognosis of various diseases (cardiac or noncardiac diseases.However, little is known about the predictive values of NLR and PLR in gestational DM, preeclampsia and the other pregnancy complications.
Retrospective data were collected for patients who was diagnosed with , preeclampsia- eclampsia, The NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal pregnancy outcomes
do not expect poor pregnancy outcomes on normal patients
high neutrophil to lymphocyte ratio
normal neutrophil-to Lymphocyte ratio
adverse pregnancy outcome
high ratio of Neutrophil / lymphocyte ratio may predict preeclampsia eclampsia
high neutrophil to lymphocyte ratio
normal neutrophil-to Lymphocyte ratio
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high neutrophil to lymphocyte ratio
normal neutrophil-to Lymphocyte ratio
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zekai Tahir Burak Women's Health Research and Education Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayse Kirbas
Ayse Kirbas, MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ayse kirbas
Role: PRINCIPAL_INVESTIGATOR
Zekai Tahir Burak Women's Health Research and Education Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zekai Tahir Burak Maternity Teaching Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
ali ersoy
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Zekai Tahir Burak
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.